These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17641995)

  • 1. American Association for Cancer Research 98th Annual Meeting. Anticancer agents - Part III.
    Sovran L
    IDrugs; 2007 Jun; 10(6):362-5. PubMed ID: 17641995
    [No Abstract]   [Full Text] [Related]  

  • 2. American Association for Cancer Research 98th Annual Meeting. Anticancer agents - Part I.
    Kneller S
    IDrugs; 2007 Jun; 10(6):356-8. PubMed ID: 17641993
    [No Abstract]   [Full Text] [Related]  

  • 3. American Association for Cancer Research--99th Annual Meeting. Clinical and preclinical data on promising therapeutics.
    Karger GA; Lee W
    IDrugs; 2008 Jun; 11(6):415-7. PubMed ID: 18509781
    [No Abstract]   [Full Text] [Related]  

  • 4. American Association for Cancer Research 98th Annual Meeting. Anticancer agents - Part II.
    Filson S
    IDrugs; 2007 Jun; 10(6):359-61. PubMed ID: 17641994
    [No Abstract]   [Full Text] [Related]  

  • 5. Antimitotic inhibitors.
    Campos SM; Dizon DS
    Hematol Oncol Clin North Am; 2012 Jun; 26(3):607-28, viii-ix. PubMed ID: 22520982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging therapies for colorectal cancer.
    Hezel AF; Ryan DP
    Expert Opin Investig Drugs; 2007 Jun; 16(6):867-76. PubMed ID: 17501698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a future for Aurora kinase inhibitors for anticancer therapy?
    Carpinelli P; Moll J
    Curr Opin Drug Discov Devel; 2009 Jul; 12(4):533-42. PubMed ID: 19562649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New inhibitors of the mammalian target of rapamycin signaling pathway for cancer.
    Albert S; Serova M; Dreyer C; Sablin MP; Faivre S; Raymond E
    Expert Opin Investig Drugs; 2010 Aug; 19(8):919-30. PubMed ID: 20569080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aurora A and B kinases--targets of novel anticancer drugs.
    Libertini S; Abagnale A; Passaro C; Botta G; Portella G
    Recent Pat Anticancer Drug Discov; 2010 Nov; 5(3):219-41. PubMed ID: 20524930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tubulin-associated drug targets: Aurora kinases, Polo-like kinases, and others.
    Warner SL; Gray PJ; Von Hoff DD
    Semin Oncol; 2006 Aug; 33(4):436-48. PubMed ID: 16890798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aurora kinases: new targets for cancer therapy.
    Carvajal RD; Tse A; Schwartz GK
    Clin Cancer Res; 2006 Dec; 12(23):6869-75. PubMed ID: 17145803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. American Association of Cancer Research--95th annual meeting. Kinases. 27-31 March, 2004, Orlando, FL, USA.
    Kibble A; Davies J
    IDrugs; 2004 May; 7(5):411-3. PubMed ID: 15154094
    [No Abstract]   [Full Text] [Related]  

  • 13. Discovery of pyrazolo[1,5-a]pyridines as p110α-selective PI3 kinase inhibitors.
    Kendall JD; O'Connor PD; Marshall AJ; Frédérick R; Marshall ES; Lill CL; Lee WJ; Kolekar S; Chao M; Malik A; Yu S; Chaussade C; Buchanan C; Rewcastle GW; Baguley BC; Flanagan JU; Jamieson SM; Denny WA; Shepherd PR
    Bioorg Med Chem; 2012 Jan; 20(1):69-85. PubMed ID: 22177405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and development of aurora kinase inhibitors as anticancer agents.
    Pollard JR; Mortimore M
    J Med Chem; 2009 May; 52(9):2629-51. PubMed ID: 19320489
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular targets for the treatment of testicular germ cell tumors.
    Chieffi P
    Mini Rev Med Chem; 2007 Jul; 7(7):755-9. PubMed ID: 17627586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aurora kinase inhibitors as anti-cancer therapy.
    Lok W; Klein RQ; Saif MW
    Anticancer Drugs; 2010 Apr; 21(4):339-50. PubMed ID: 20016367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aurora kinase inhibitors.
    Kitzen JJ; de Jonge MJ; Verweij J
    Crit Rev Oncol Hematol; 2010 Feb; 73(2):99-110. PubMed ID: 19369091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel anticancer therapeutics targeting the PI3K/Akt/mTOR pathway.
    Maira SM; Furet P; Stauffer F
    Future Med Chem; 2009 Apr; 1(1):137-55. PubMed ID: 21426073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.
    Faivre S; Djelloul S; Raymond E
    Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mTOR pathway inhibitors in cancer therapy: moving past rapamycin.
    Wacheck V
    Pharmacogenomics; 2010 Sep; 11(9):1189-91. PubMed ID: 20860456
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.